XNASDH
Market cap459mUSD
Jan 15, Last price
3.98USD
1D
1.53%
1Q
-10.96%
IPO
-91.57%
Name
Definitive Healthcare Corp
Chart & Performance
P/E
—
P/S
1.83
EPS
—
Div Yield, %
2.67%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
251m
+12.92%
Net income
-202m
L+809.40%
CFO
41m
+15.77%
Earnings
Feb 26, 2025
Profile
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | 251,415 12.92% | 222,653 34.00% | |||
Cost of revenue | 243,318 | 215,881 | |||
Unusual Expense (Income) | |||||
NOPBT | 8,097 | 6,772 | |||
NOPBT Margin | 3.22% | 3.04% | |||
Operating Taxes | (18,553) | (17,185) | |||
Tax Rate | |||||
NOPAT | 26,650 | 23,957 | |||
Net income | (202,388) 809.40% | (22,255) -63.67% | |||
Dividends | (12,282) | (12,871) | |||
Dividend yield | 1.10% | 1.16% | |||
Proceeds from repurchase of equity | (4,462) | (5,850) | |||
BB yield | 0.40% | 0.53% | |||
| Debt | |||||
Debt current | 15,989 | 10,115 | |||
Long-term debt | 263,550 | 277,224 | |||
Deferred revenue | 9 | 236 | |||
Other long-term liabilities | 136,934 | 159,562 | |||
Net debt | (29,038) | (47,368) | |||
| Cash flow | |||||
Cash from operating activities | 41,190 | 35,579 | |||
CAPEX | (2,977) | (8,326) | |||
Cash from investing activities | (31,782) | (248,903) | |||
Cash from financing activities | (25,584) | (26,696) | |||
FCF | 26,730 | 14,881 | |||
| Balance | |||||
Cash | 308,068 | 331,873 | |||
Long term investments | 509 | 2,834 | |||
Excess cash | 296,006 | 323,574 | |||
Stockholders' equity | 112,593 | 515,144 | |||
Invested Capital | 1,491,452 | 1,595,663 | |||
ROIC | 1.73% | 1.54% | |||
ROCE | 0.48% | 0.34% | |||
| EV | |||||
Common stock shares outstanding | 112,765 | 101,114 | |||
Price | 9.94 -9.55% | 10.99 -59.79% | |||
Market cap | 1,120,879 0.87% | 1,111,244 -58.10% | |||
EV | 1,429,658 | 1,598,961 | |||
EBITDA | 59,847 | 63,676 | |||
EV/EBITDA | 23.89 | 25.11 | |||
Interest | 15,203 | 8,413 | |||
Interest/NOPBT | 187.76% | 124.23% | |||